Cargando…

Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia

Human cytomegalovirus (HCMV) is a widely prevalent herpes virus which establishes a state of chronic infection. The establishment of CMV‐specific immunity controls viral reactivation and leads to the accumulation of very large numbers of virus‐specific T cells which come to dominate the immune reper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parry, Helen Marie, Damery, Sarah, Hudson, Christopher, Maurer, Matthew J., Cerhan, James R., Pachnio, Annette, Begum, Jusnara, Slager, Susan L., Fegan, Christopher, Man, Stephen, Pepper, Christopher, Shanafelt, Tait D., Pratt, Guy, Moss, Paul A. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957613/ https://www.ncbi.nlm.nih.gov/pubmed/27124884 http://dx.doi.org/10.1002/ajh.24403

Ejemplares similares

Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals
por: Pachnio, Annette, et al.
Publicado: (2015)

The Cellular Localization of Human Cytomegalovirus Glycoprotein Expression Greatly Influences the Frequency and Functional Phenotype of Specific CD4(+) T Cell Responses
por: Pachnio, Annette, et al.
Publicado: (2015)

Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium
por: Pachnio, Annette, et al.
Publicado: (2016)

PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicity
por: Parry, Helen M., et al.
Publicado: (2021)

Long-Term Ibrutinib Therapy Reverses CD8(+) T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia
por: Parry, Helen M., et al.
Publicado: (2019)

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index
por: Wang, Yucai, et al.
Publicado: (2021)

Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
por: Paneesha, S., et al.
Publicado: (2020)

Cytomegalovirus-Specific T Cells Restricted by HLA-Cw*0702 Increase Markedly with Age and Dominate the CD8(+) T-Cell Repertoire in Older People
por: Hosie, Louise, et al.
Publicado: (2017)

Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Burley, Thomas A., et al.
Publicado: (2022)

Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
por: Clay-Gilmour, Alyssa I., et al.
Publicado: (2019)

Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia
por: Sfeir, J G, et al.
Publicado: (2017)

Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia
por: Tschumper, Renee C., et al.
Publicado: (2019)

Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
por: Burley, Thomas A., et al.
Publicado: (2022)

Cytomegalovirus drives Vδ2(neg) γδ T cell inflation in many healthy virus carriers with increasing age
por: Alejenef, A, et al.
Publicado: (2014)

Risk of Non-hematologic Cancer in Individuals with High Count Monoclonal B-Cell Lymphocytosis (MBL)
por: Solomon, Benjamin M., et al.
Publicado: (2015)

BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib
por: Jackson, Ross A., et al.
Publicado: (2023)

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy
por: Sinha, Sutapa, et al.
Publicado: (2018)

Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years
por: Parry, Helen M., et al.
Publicado: (2016)

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans
por: Kleinstern, Geffen, et al.
Publicado: (2021)

COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
por: Parry, Helen, et al.
Publicado: (2022)

Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases
por: Abbott, Rachel J., et al.
Publicado: (2017)

Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia
por: Lin, Wei-Yu, et al.
Publicado: (2021)

Dynamics of Microvesicle Generation in B Cell Chronic Lymphocytic Leukemia: Implication in Disease Progression
por: Boysen, Justin, et al.
Publicado: (2016)

Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia
por: Parry, H., et al.
Publicado: (2021)

Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts
por: Davies, Nicholas J., et al.
Publicado: (2017)

P627: LONG-TERM OUTCOMES WITH CONTINUOUS IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: ANALYSIS OF TIME TO PROGRESSION
por: Kipps, Thomas, et al.
Publicado: (2023)

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice
por: Parikh, Sameer A., et al.
Publicado: (2020)

A Career in Surgical Oncology: Finding Meaning, Balance, and Personal Satisfaction
por: Shanafelt, Tait
Publicado: (2007)

NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma
por: Parry, Helen M., et al.
Publicado: (2016)

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia
por: Kay, Neil E., et al.
Publicado: (2016)

Cytomegalovirus induced hemophagocytic lymphocytic histiocytosis in two pediatric patients with acute lymphoblastic leukemia
por: Waddell, Benjamin, et al.
Publicado: (2017)

Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients
por: Singh, Namrata, et al.
Publicado: (2020)

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study
por: Hillmen, Peter, et al.
Publicado: (2019)

CD4+ cells as a potential biomarker for cytomegalovirus retinitis in children with acute lymphocytic leukemia
por: Wang, Jian-Cang, et al.
Publicado: (2019)

Cytomegalovirus Proctitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: A Case Report
por: Reddy, Yeshaswini, et al.
Publicado: (2020)

A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia
por: Cohen, Jared A., et al.
Publicado: (2020)

Supporting Peer Supporters
por: Shanafelt, Tait, et al.
Publicado: (2022)

Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
por: Parry, Helen, et al.
Publicado: (2022)

The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis
por: Parikh, Sameer A., et al.
Publicado: (2022)

Cytomegalovirus keratitis in acute myeloblastic leukemia
por: Daryabari, Seyed-Hashem, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g3cc4vruc43goks6v2u7t0c075